Equity · Healthcare
PHAT
NASDAQPhathom Pharmaceuticals (PHAT)
The line runs 9.29 USD on 17 August through 6.08 USD on 13 November, on a scale from 4 to 10. Days the market did not trade hold the previous close, flat.
- Market cap
- 494.3M USD
- Revenue, year to Dec 2025
- 175.1M USD
- EPS, diluted, year to Dec 2025
- −3.03 USD
- 52-week range
- 5.07 USD – 18 USD
- Avg volume
- 128.8K
- Mentions, 30 days
- 15
- Net sentiment
- +0.05
as of Nov 13, 2026
Have Phathom Pharmaceuticals (PHAT) insiders bought or sold shares recently?
In the 90 days to 15 Nov 2026, no Phathom Pharmaceuticals insider bought or sold shares on the open market; all 2 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).
Form 4, 90 days to 15 Nov 2026, newest Form 4 filing 6 Oct 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 06 Oct 2026 | Narula SanjeevChief Financial & Bus. Officer | Tax withheld | 13,485 | 91K USD |
| 03 Sep 2026 | Breedlove Robert CharlesPrincipal Accounting Officer | Tax withheld | 460 | 4K USD |
Which funds hold Phathom Pharmaceuticals (PHAT)?
1 of the 45 institutional funds we track reported a Phathom Pharmaceuticals position for the quarter ended 30 Sep 2026 — a combined 160K USD; the latest of those filings landed 13 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Renaissance Technologies | Trimmed | 21,909 | 160K USD | −90.3% |
| Marshall Wace | Exited |
What has been filed or recorded for Phathom Pharmaceuticals (PHAT)?
The filings we hold for Phathom Pharmaceuticals, newest first: 1 fails-to-deliver day, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 14 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 14 Oct 2026 | Fails to deliver | Shares failed to deliver | 8,556 shares | 60K USD notional · 0.011% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS −0.16 USD | Revenue $85M |
| 30 Sep 2026 | Financials | Total assets | 345.0M USD | at period end |
| 30 Sep 2026 | Financials | Total equity | −347.6M USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.21 USD | Revenue $74M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −0.37 USD | Revenue $58M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS −3.03 USD | Revenue $175M |
| 31 Dec 2025 | Financials | Revenue | 175.1M USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | −221.2M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | −3.03 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −0.41 USD | Revenue $50M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS −1.05 USD | Revenue $40M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS −1.31 USD | Revenue $29M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −5.29 USD | Revenue $55M |
What is Reddit saying about Phathom Pharmaceuticals (PHAT)?
Reddit mentioned PHAT 15 times in the 30 days to 14 November 2026, in 1 of the communities we track. All of them were scored for sentiment: 47% read bullish, 7% bearish and 46% neither. Reddit data updated 14 November 2026.
30-day window, Method
How do Reddit mentions of Phathom Pharmaceuticals (PHAT) compare with its price?
Share ↗
Which subreddits are talking about Phathom Pharmaceuticals (PHAT)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 100% | 15 | +0.05 |
Which names move with Phathom Pharmaceuticals (PHAT) on Reddit?
WHEAT moved most closely with Phathom Pharmaceuticals (PHAT): when the crowd talked about one, it talked about the other (+0.69 over 31 days). Co-discussion, not price.
WHEAT | ARMCO | |||||
|---|---|---|---|---|---|---|
PHAT | +0.69 | +0.67 | +0.63 | +0.62 | +0.61 | +0.60 |
View the matrix as a tableHide the table
| Pair | Match | Days measured |
|---|---|---|
| PHAT and WHEAT | +0.69 | 31 days |
| PHAT and TLX | +0.67 | 31 days |
| PHAT and SIM | +0.63 | 31 days |
| PHAT and ARMCO | +0.62 | 31 days |
| PHAT and VDE | +0.61 | 31 days |
| PHAT and SMTH | +0.60 | 31 days |
What do people ask about Phathom Pharmaceuticals (PHAT)?
What did Phathom Pharmaceuticals shares close at?6.08
Phathom Pharmaceuticals closed at 6.08 USD on 13 Nov 2026, down 2.49% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Phathom Pharmaceuticals’ market cap?494.3M
Phathom Pharmaceuticals is worth 494.3M USD by market value as of 13 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is Phathom Pharmaceuticals’ revenue?175.1M
Phathom Pharmaceuticals reported revenue of 175.1M USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Phathom Pharmaceuticals insiders bought or sold shares recently?2 filings
In the 90 days to 15 Nov 2026, no Phathom Pharmaceuticals insider bought or sold shares on the open market; all 2 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders
Which funds own Phathom Pharmaceuticals?1 of 45
1 of the 45 funds we track reported a Phathom Pharmaceuticals position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Renaissance Technologies and Marshall Wace. See Funds
When did Phathom Pharmaceuticals last report earnings?−0.16
Phathom Pharmaceuticals last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of −0.16 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Phathom Pharmaceuticals?2 mentions
Phathom Pharmaceuticals was mentioned 2 times in the last 7 days across the finance subreddits we track, and 15 times over the trailing 30 days. Of the 15 mentions scored for sentiment, 47% read bullish and 7% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings